European Journal of Clinical Pharmacology

Papers
(The H4-Index of European Journal of Clinical Pharmacology is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Association study identifies genetic determinants and non-genetic factors on steady-state plasma and therapeutic outcome of galantamine in mixed dementia139
A Study Of the effect of Sex on drug dosing, concentrations, and pharmacogenomics in the Montreal Heart Institute Hospital Cohort (SOS-PGx): methodology and research progress51
Use of overactive bladder anticholinergic medications associated with falls leading to emergency department visits: results from the ADRED study48
Understanding attitudes towards psychiatric medications: a comparative study of patients, healthcare professionals, and general population perspectives40
Signal detection between 5-alpha reductase inhibitors and the risk of suicidality and depression: an international pharmacovigilance analysis40
Might chronic spontaneous urticaria develop after SARS-CoV-2 vaccinations?31
Anticholinergic burden and cognitive performance: cross-sectional results from the ELSA-Brasil study31
Oral Melatonin for Pain Relief During Venepuncture in Neonates– a Pilot Randomized Control Trial29
Population pharmacokinetics and pharmacodynamics of meropenem in critically ill patients with renal impairment or on continuous renal replacement therapy26
Lowering cyclosporine trough concentration threshold effectively mitigates acute graft-versus-host disease in children with severe β-Thalassemia post hematopoietic stem cell transplantation26
Usefulness of mirtazapine and SSRIs in late-life depression: post hoc analysis of the GUNDAM study26
A phase 1 study in healthy participants to characterize the safety and pharmacology of inclacumab, a fully human anti-P-selectin antibody, in development for treatment of sickle cell disease26
Incidence and risk factors of drug-induced kidney injury in children: a systematic review and meta-analysis25
Medication adherence among persons with coronary heart disease and associations with blood pressure and low-density-lipoprotein-cholesterol25
Effects of sodium-glucose cotransporter 2 inhibitors on renal risk factors in patients with abnormal glucose metabolism: a meta-analysis of randomized controlled trials24
How to make the best of NLRP3 inhibitors in patients with COVID-19?24
Comment on “Use of statins and risks of ovarian, uterine, and cervical diseases: a cohort study in the UK Biobank”23
The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis23
Relationship between CYP2C8, UGT1A1, and ABCG2 gene polymorphisms and the exposure, efficacy, and toxicity of eltrombopag in the treatment of refractory aplastic anemia23
Pharmacokinetics of mycophenolic acid and external evaluation of two limited sampling strategies of drug exposure in patients with juvenile systematic lupus erythematosus23
Assessment of body mass-related covariates for rifampicin pharmacokinetics in healthy Caucasian volunteers22
Self-reported adherence to direct oral anticoagulants versus warfarin therapy in a specialized thrombosis service—a cross-sectional study of patients in a Canadian Health Region22
0.079431056976318